Related Experiment Videos
Aminoglycosides in the intensive care unit: an old drug in a dynamic environment
1Department of Pharmacy, University of Cincinnati College of Medicine, OH 45267-0740.
Abstract:
Aminoglycosides have historically been the mainstay of antibiotic therapy in the ICU. Despite the availability of numerous less toxic antibiotics, the clinical and microbiologic attributes of these agents have ensured their continued use in the management of infections in the critically ill patient. Innovative dosing regimens may replace traditional dosing methods if they are shown to provide improved clinical response with less toxicity potential.
Insights
Aminoglycosides remain crucial for treating ICU infections due to their effectiveness. New dosing strategies may enhance clinical outcomes and reduce toxicity in critically ill patients.
Area of Science:
- Pharmacology
- Infectious Diseases
- Critical Care Medicine
Background:
- Aminoglycosides are historically significant antibiotics in intensive care unit (ICU) settings.
- Despite newer, less toxic alternatives, aminoglycosides are still vital for managing infections in critically ill patients.
Purpose of the Study:
- To review the continued clinical and microbiologic relevance of aminoglycosides in ICU infections.
- To explore the potential of innovative dosing regimens to improve efficacy and reduce toxicity.
Main Methods:
- Literature review of aminoglycoside use in critically ill patients.
- Analysis of clinical and microbiologic data supporting aminoglycoside efficacy.
- Evaluation of emerging dosing strategies and their impact on patient outcomes.
Main Results:
- Aminoglycosides possess unique clinical and microbiologic properties that sustain their use.
- Current evidence supports the ongoing role of aminoglycosides in specific ICU infection scenarios.
- Innovative dosing regimens show promise for optimizing aminoglycoside therapy.
Conclusions:
- Aminoglycosides remain indispensable in the ICU armamentarium for specific infections.
- Further research into novel dosing strategies is warranted to maximize benefits and minimize risks.
- Optimized aminoglycoside therapy can improve patient response and safety in critical care.